Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giaccone

Showing results (201-210 of 359) with videos related to

Pageof 36
Sort By:
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative GroupG Anderson, M Clavel, J Smyth, et al.
British Journal of Cancer|June 3, 2004
Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAILM A I Abou El Hassan, D C J Mastenbroek, W R Gerritsen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, G Giaccone, C J van Moorsel, et al.
Neurobiology of Aging|June 15, 2007
Tauopathy in human and experimental variant Creutzfeldt-Jakob diseaseG Giaccone, M Mangieri, R Capobianco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liverJ M G H van Riel, C J van Groeningen, J de Greve, et al.
British Journal of Cancer|October 1, 1992
Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter platesP E Pizao, D M Lyaruu, G J Peters, et al.
Neurology|August 10, 2000
Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP geneG Rossi, G Giaccone, L Giampaolo, et al.
Cancer|August 1, 1986
Thymomas. A review of 169 cases, with particular reference to results of surgical treatmentG Maggi, G Giaccone, M Donadio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupK Mattson, G Giaccone, A Kirkpatrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancerA W Tolcher, D I Quinn, A Ferrari, et al.
Pageof 36

Showing results (201-210 of 359) with videos related to

Sort By:
Pageof 36
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative GroupG Anderson, M Clavel, J Smyth, et al.
British Journal of Cancer|June 3, 2004
Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAILM A I Abou El Hassan, D C J Mastenbroek, W R Gerritsen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, G Giaccone, C J van Moorsel, et al.
Neurobiology of Aging|June 15, 2007
Tauopathy in human and experimental variant Creutzfeldt-Jakob diseaseG Giaccone, M Mangieri, R Capobianco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liverJ M G H van Riel, C J van Groeningen, J de Greve, et al.
British Journal of Cancer|October 1, 1992
Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter platesP E Pizao, D M Lyaruu, G J Peters, et al.
Neurology|August 10, 2000
Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP geneG Rossi, G Giaccone, L Giampaolo, et al.
Cancer|August 1, 1986
Thymomas. A review of 169 cases, with particular reference to results of surgical treatmentG Maggi, G Giaccone, M Donadio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative GroupK Mattson, G Giaccone, A Kirkpatrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancerA W Tolcher, D I Quinn, A Ferrari, et al.
Pageof 36